Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H M Mcclure

Showing results (111-120 of 149) with videos related to

Pageof 15
Sort By:
Annals of the New York Academy of Sciences|January 1, 1990
Antiretroviral activity, biochemistry, and pharmacokinetics of 3'-azido-2',3'-dideoxy-5-methylcytidineR F Schinazi, C K Chu, B F Eriksson, et al.
Immunologic Research|May 10, 2000
Multi-envelope HIV vaccine safety and immunogenicity in small animals and chimpanzeesT D Lockey, K S Slobod, T E Caver, et al.
Journal of Virology|January 11, 2001
Rapid CD4(+) T-cell loss induced by human immunodeficiency virus type 1(NC) in uninfected and previously infected chimpanzeesF J Novembre, J de Rosayro, S Nidtha, et al.
AIDS (London, England)|May 1, 1990
Requirements for simian immunodeficiency virus antigen-specific in vitro proliferation of T cells from infected rhesus macaques and sooty mangabeysA Ahmed-Ansari, J D Powell, P E Jensen, et al.
Virology|January 9, 2001
Sequential immunization of macaques with two differentially attenuated vaccines induced long-term virus-specific immune responses and conferred protection against AIDS caused by heterologous simian human immunodeficiency Virus (SHIV(89.6)P)A Kumar, J D Lifson, Z Li, et al.
European Journal of Immunology|December 18, 2001
Emergence of cytotoxic T lymphocyte escape mutations in nonpathogenic simian immunodeficiency virus infectionA Kaur, L Alexander, S I Staprans, et al.
AIDS Research and Human Retroviruses|February 1, 1990
3'-Azido-2',3'-dideoxyuridine (AzddU): comparative pharmacokinetics with 3'-azido-3'-deoxythymidine (AZT) in monkeysF D Boudinot, R F Schinazi, J M Gallo, et al.
Blood|June 17, 1998
Treatment of thrombocytopenia in chimpanzees infected with human immunodeficiency virus by pegylated recombinant human megakaryocyte growth and development factorL A Harker, U M Marzec, F Novembre, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 1, 1990
Polyclonal B-cell activation reveals antibodies against human immunodeficiency virus type 1 (HIV-1) in HIV-1-seronegative individualsT Jehuda-Cohen, B A Slade, J D Powell, et al.
Antimicrobial Agents and Chemotherapy|April 2, 1999
Pharmacokinetics of beta-L-2',3'-dideoxy-5-fluorocytidine in rhesus monkeysL T Martin, E Cretton-Scott, R F Schinazi, et al.
Pageof 15

Showing results (111-120 of 149) with videos related to

Sort By:
Pageof 15
Annals of the New York Academy of Sciences|January 1, 1990
Antiretroviral activity, biochemistry, and pharmacokinetics of 3'-azido-2',3'-dideoxy-5-methylcytidineR F Schinazi, C K Chu, B F Eriksson, et al.
Immunologic Research|May 10, 2000
Multi-envelope HIV vaccine safety and immunogenicity in small animals and chimpanzeesT D Lockey, K S Slobod, T E Caver, et al.
Journal of Virology|January 11, 2001
Rapid CD4(+) T-cell loss induced by human immunodeficiency virus type 1(NC) in uninfected and previously infected chimpanzeesF J Novembre, J de Rosayro, S Nidtha, et al.
AIDS (London, England)|May 1, 1990
Requirements for simian immunodeficiency virus antigen-specific in vitro proliferation of T cells from infected rhesus macaques and sooty mangabeysA Ahmed-Ansari, J D Powell, P E Jensen, et al.
Virology|January 9, 2001
Sequential immunization of macaques with two differentially attenuated vaccines induced long-term virus-specific immune responses and conferred protection against AIDS caused by heterologous simian human immunodeficiency Virus (SHIV(89.6)P)A Kumar, J D Lifson, Z Li, et al.
European Journal of Immunology|December 18, 2001
Emergence of cytotoxic T lymphocyte escape mutations in nonpathogenic simian immunodeficiency virus infectionA Kaur, L Alexander, S I Staprans, et al.
AIDS Research and Human Retroviruses|February 1, 1990
3'-Azido-2',3'-dideoxyuridine (AzddU): comparative pharmacokinetics with 3'-azido-3'-deoxythymidine (AZT) in monkeysF D Boudinot, R F Schinazi, J M Gallo, et al.
Blood|June 17, 1998
Treatment of thrombocytopenia in chimpanzees infected with human immunodeficiency virus by pegylated recombinant human megakaryocyte growth and development factorL A Harker, U M Marzec, F Novembre, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 1, 1990
Polyclonal B-cell activation reveals antibodies against human immunodeficiency virus type 1 (HIV-1) in HIV-1-seronegative individualsT Jehuda-Cohen, B A Slade, J D Powell, et al.
Antimicrobial Agents and Chemotherapy|April 2, 1999
Pharmacokinetics of beta-L-2',3'-dideoxy-5-fluorocytidine in rhesus monkeysL T Martin, E Cretton-Scott, R F Schinazi, et al.
Pageof 15